Evaluating the quality of prostate cancer diagnosis recording in routinely collected primary care data for observational research: A study using multiple linked English electronic health records databases
Batheegama Gamarachchige, G.; Ford, E.; Armes, J.; Moschoyiannis, S.; Collins, M.; Francsics, P.; Lemanska, A.
Show abstract
BackgroundPrimary care data in the UK are widely used for cancer research, but the reliability of recording key events such as diagnoses remains uncertain. Data linkage can mitigate these uncertainties; however, researchers may avoid linkage due to high costs, tight timelines, and sample size limitations. Hence, this study aimed to assess the quality of prostate cancer (PCa) diagnoses in primary care. We utilised Clinical Practice Research Datalink (CPRD) primary care data linked to National Cancer Registration and Analysis Service (NCRAS) and Hospital Episode Statistics (HES) in England. We compared accuracy, completeness, and timing of diagnosis recording between sources to facilitate decision-making regarding data source selection for future research. MethodsIncident PCa diagnoses (2000-2016) for males aged [≥]46 years recorded in at least one study data source were examined. The accuracy of a data source was estimated by the proportion of diagnoses recorded in the specific source that was also confirmed by any linked source. Completeness was estimated by identifying the proportion of all diagnoses in linked sources with a matching diagnosis in the specific source. ResultsThe study included 51,487 PCa patients from either source. CPRD demonstrated 86.9% accuracy and 68.2% completeness against NCRAS and 75.1% accuracy and 61.1% completeness against HES. Overall, CPRD showed the highest accuracy (93%) but the lowest completeness (60.7%). Diagnosis dates in CPRD were more concordant with NCRAS (90.6% within 6 months) than with HES (61.2%). Over time, accuracy and completeness improved, especially after 2004. Discrepancies in diagnosis dates revealed a median delay of 2 weeks in CPRD than NCRAS and 1 week than HES. CPRD Aurum exhibited better quality compared to GOLD. ConclusionsWhile the accuracy of PCa diagnoses in CPRD compared to linked sources was high, completeness was low. Therefore, linking to HES or NCRAS should be considered for improved case capture, acknowledging their inherent limitations.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Prescribing patterns for medical treatment of suspected prostatic obstruction: A spatiotemporal statistical analysis of Scottish open access data 93%
- Development and validation of multivariable machine learning algorithms to predict risk of cancer in symptomatic patients referred urgently from primary care 92%
- Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol 91%
Similar papers in this journal
- Development and validation of a modified Cambridge Multimorbidity Score for use with internationally recognized electronic health record clinical terms (SNOMED CT) 92%
- OpenSAFELY NHS Service Restoration Observatory 1: describing trends and variation in primary care clinical activity for 23.3 million patients in England during the first wave of COVID-19 91%
- Suspected COVID-19 in primary care: how GP records contribute to understanding differences in prevalence by ethnicity. 90%
Similar papers in this journal
- Enhancing Palliative Care Registration Using an Automated Robotic Process with Clinician Validation: A PRADA Prospective Cohort Study. 90%
- A mixed-methods evaluation of patients’ views on primary care multi-disciplinary teams in Scotland 90%
- Patient characteristics associated with clinically coded long COVID: an OpenSAFELY study using electronic health records 89%
Similar papers in this journal
- Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study 93%
- A prospective validation of nomograms based on BC-116 and BC-106 urine peptide biomarker panels for bladder cancer diagnostics and monitoring 91%
- Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.